Cargando…
Geranylgeranyl pyrophosphate depletion by statins compromises skeletal muscle insulin sensitivity
BACKGROUND: Statins are widely prescribed cholesterol‐lowering drugs but have been shown to increase the risk of type 2 diabetes mellitus. However, the molecular mechanisms underlying the diabetogenic effect of statins are still not fully understood. METHODS: The effects of geranylgeranyl transferas...
Autores principales: | Wang, Lai, Zheng, Zuguo, Zhu, Lijun, Meng, Lingchang, Liu, Hanling, Wang, Keke, Chen, Jun, Li, Ping, Yang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745480/ https://www.ncbi.nlm.nih.gov/pubmed/35961942 http://dx.doi.org/10.1002/jcsm.13061 |
Ejemplares similares
-
Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes PCSK9–Dependent Adipose Insulin Resistance
por: Shu, Xin, et al.
Publicado: (2022) -
Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes Ferroptosis-Related Senescence in Adipose Tissue
por: Shu, Xin, et al.
Publicado: (2022) -
Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation
por: Vosper, Jonathan, et al.
Publicado: (2014) -
Effects of mevalonate kinase interference on cell differentiation, apoptosis, prenylation and geranylgeranylation of human keratinocytes are attenuated by farnesyl pyrophosphate or geranylgeranyl pyrophosphate
por: Li, Min, et al.
Publicado: (2020) -
Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma
por: Yanae, Masashi, et al.
Publicado: (2011)